ID   MOLP-3
AC   CVCL_5764
SY   MOLP3
DR   Wikidata; Q54906336
RX   PubMed=8148313;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgD lambda.
CC   Doubling time: ~96 hours (PubMed=8148313).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2123 ! MOLP-2
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
RX   PubMed=8148313;
RA   Matsuo Y., Nakamura S., Adachi T., Tsubota T.;
RT   "Establishment and characterization of new IgD lambda type myeloma
RT   cell lines, MOLP-2 and MOLP-3, expressing CD28, CD33 antigens and the
RT   IL-6 receptor.";
RL   Hum. Cell 6:310-313(1993).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//